Aspen Neuroscience
ID: 7642816Aspen Neuroscience develops autologous iPSC-derived cell replacement therapies for Parkinson’s disease and other CNS disorders.
3
Funding Rounds
$224.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Je**** Lo**** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ho**** J. Fe****** | - | - |
Funding
Funding series
Funding Series Analysis
The company Aspen Neuroscience has raised a total of $154m in funding over 3 rounds.
Key Insights:
- Aspen Neuroscience Series B round, May 2022: $147.5m
- Aspen Neuroscience Seed round, December 2019: $6.5m
- Aspen Neuroscience Series A round Apr 1, 2020: $70m
Industries
Aspen Neuroscience is active in the following industries: